Synthesis of [methoxy-3H]- and [methoxy-11C]- labelled raclopride. Specific dopamine-D2 receptor ligands
暂无分享,去创建一个
T. Högberg | E. Ehrin | Thomas Högberg | P. Ström | E. Ehrin | Lars Gawell | Tomas De Paulis | Peter Ström | T. D. Paulis | L. Gawell | Erling Ehrin | T. Paulis
[1] H. Hall,et al. Preparation of tritium labelled benzamide dopamine‐D2 lignads at high specific activity , 1985 .
[2] H. Hall,et al. Effects of remoxipride and some related new substituted salicylamides on rat brain receptors. , 2009, Acta pharmacologica et toxicologica.
[3] J. C. Stoof,et al. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum , 1981, Nature.
[4] M. Dubocovich,et al. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. , 1983, The Journal of pharmacology and experimental therapeutics.
[5] H. Hall,et al. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. , 2009, Acta pharmacologica et toxicologica.
[6] T Greitz,et al. Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. , 1985, The International journal of applied radiation and isotopes.
[7] T Greitz,et al. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Seeman. Brain dopamine receptors. , 1980, Pharmacological reviews.
[9] S O Ogren,et al. Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides. , 1986, Journal of medicinal chemistry.
[10] H. Hall,et al. Some in vitro receptor binding properties of [3H]eticlopride, a novel substituted benzamide, selective for dopamine-D2 receptors in the rat brain. , 1985, European journal of pharmacology.
[11] C. Finch,et al. Contamination of serotonin-2 binding sites by an alpha-1 adrenergic component in assays with (3H)spiperone. , 1984, Life sciences.
[12] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[13] J. Leysen,et al. Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity. , 1979, Biochemical pharmacology.
[14] H. Hall,et al. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain. , 1984, European journal of pharmacology.
[15] S. Snyder,et al. 3H-Spiroperidol labels dopamine receptors in pituitary and brain. , 1977, European journal of pharmacology.
[16] J. Leysen,et al. Spiperone: a ligand of choice for neuroleptic receptors. 2. Regional distribution and in vivo displacement of neuroleptic drugs. , 1978, Biochemical pharmacology.
[17] H. Hall,et al. Regional in vivo binding of the substituted benzamide [3H]eticlopride in the rat brain: evidence for selective labelling of dopamine receptors. , 1986, European journal of pharmacology.
[18] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[19] C. Köhler,et al. Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride , 1986, Neuroscience Letters.
[20] C. Marsden,et al. Substituted benzamide drugs as selective neuroleptic agents. , 1981, Neuropharmacology.
[21] S. Ogren,et al. Potential neuroleptic agents. 2,6-Dialkoxybenzamide derivatives with potent dopamine receptor blocking activities. , 1982, Journal of medicinal chemistry.